Market Herald logo


Be the first with the news that moves the market

The Chinese Food and Drug Administration has approved CardieX’s Oscar 2 blood pressure monitor. With more than 12 percent of annual adult deaths resulting from hypertension, this device will be used by over 20,000 physicians to detect, diagnose, monitor and manage it.

It will measure central aortic blood pressure and conduct a central pressure waveform analysis. Patients will be able to monitor blood pressure over a 24-hour period at home with results being sent to doctors and then discussed.

The monitor features SphygmoCor technology, supplied by CardieX’s subsidiary AtCor, and is manufactured by SunTech Medical.

CardieX is also looking to create additional partnerships for in-home vital sign monitoring, home-use blood pressure monitoring, digital health, and smart health wearables.

CardieX CEO Craig Cooper hopes that this partnership will benefit those experiencing hypertension.

“This collaboration highlights the way CardieX aims to develop, grow and expand into the largest and most significant health market in the world,” he said.

Earning revenue of more than $USD50 million per annum this is expected to roll out in China in the second half of 2019.

Please find the announcement here

Chart image:

CDX by the numbers
More From The Market Herald
Atomo Diagnostics (ASX:AT1) - Managing Director, John Kelly

" Atomo (ASX:AT1) approved to supply and advertise HIV Self-Test

Atomo Diagnostics (AT1) can now supply its HIV self-test to a greater variety of organisations and begin advertising thanks to recent changes made
Starpharma (ASX:SPL) - CEO, Dr Jackie Fairley

" Starpharma (ASX:SPL) signs VIRALEZE supply deal for Vietnam

Starpharma (SPL) has penned an initial deal to distribute and supply its VIRALEZE antiviral nasal spray in Vietnam.
Audio Pixels (ASX:AKP) - Chair, Fred Bart

" Audio Pixels (ASX:AKP) finds tech can extend to $30b earphone market

Audio Pixels (AKP) has found its existing digital sound reconstruction (DSR) loudspeaker technologies can extend for use in earphones and headphones.
Bluechiip (ASX:BCT) - Managing Director, Andrew McLellan

" Bluechiip (ASX:BCT) to customise tech for assisted fertility market

Sample technology company Bluechiip (BCT) has signed a two-year licence and development agreement with FUJIFILM Irvine Scientific (FISI).